Asan Medical Center Myocardial Infarction Registry (Asan-MI)

December 22, 2023 updated by: Seung-Jung Park
This study evaluates long-term outcome of patients diagnosed as acute myocardial infarction and treated with medication, coronary artery bypass surgery and percutaneous coronary intervention in Asan medical center, Korea.

Study Overview

Status

Recruiting

Conditions

Detailed Description

This study will collect 3000 cases retrospectively and 2000 cases prospectively.

Study Type

Observational

Enrollment (Estimated)

5000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

All consecutive acute myocardial infarction patients diagnosed through coronary angiography

Description

Inclusion Criteria:

  • All consecutive acute myocardial infarction patients diagnosed through coronary angiography

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Myocardial infarction
diagnosed as acute myocardial infarction and treated with medical treatment, coronary artery bypass surgery and percutaneous coronary intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
A composite event of all-cause death, non-fatal myocardial infarction and repeat revascularization
Time Frame: 1 year
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cardiac death
Time Frame: 5 year
5 year
Myocardial infarction
Time Frame: 5 year
5 year
All cause death
Time Frame: 5 year
5 year
A composite event of all-cause death and myocardial infarction
Time Frame: 5 year
5 year
A composite event of cardiac death and myocardial infarction
Time Frame: 5 year
5 year
Repeat revascularization
Time Frame: 5 year
5 year
Stent thrombosis
Time Frame: 5 year
according to Academic Research Consortium (ARC) criteria
5 year
Stroke
Time Frame: 5 year
A stroke or cerebrovascular accident with loss of neurological function caused by an ischemic or hemorrhagic event with residual symptoms at least 24 hours after onset or leading to death.
5 year
Procedure success
Time Frame: 7 days
Successful percutaneous coronary intervention at the intended target lesion with final instant residual stenosis of less than 30% by quantitative coronary angiography (QCA) and no event of death or Q wave myocardial infarction or urgent revascularization during hospitalization.
7 days
Surgery success
Time Frame: 7 days
Successful surgery defines as no event of death or Q wave myocardial infarction or urgent revascularization during hospitalization.
7 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Seung-Jung Park

Collaborators

CardioVascular Research Foundation, Korea

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 27, 2018

Primary Completion (Estimated)

December 31, 2025

Study Completion (Estimated)

December 31, 2030

Study Registration Dates

First Submitted

January 21, 2018

First Submitted That Met QC Criteria

January 21, 2018

First Posted (Actual)

January 26, 2018

Study Record Updates

Last Update Posted (Actual)

December 26, 2023

Last Update Submitted That Met QC Criteria

December 22, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • AMCCV2018-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Coronary Stenosis

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahamas

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe